The first case was an arthroscopic ankle fusion, according to a news release. OssiGraft Prime is derived from donors with a median age of 35 and a maximum age of 55, and it has a high composition of cancellous bone to promote faster bone regeneration.
OssiGraft Prime is available nationwide to orthopedic surgeons.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
